Health-related quality of life of Iranian breast cancer patients: a meta-analysis and systematic review Salehoddin BouyaMaryam koochakzaiMahnaz Didehvar Review 14 March 2018 Pages: 205 - 212
Mutant p53 in breast cancer: potential as a therapeutic target and biomarker Michael J. DuffyNaoise C. SynnottJohn Crown Review 21 March 2018 Pages: 213 - 219
Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer Tia H. TurnerMohammad A. AlzubiJ. Chuck Harrell Preclinical study 12 March 2018 Pages: 221 - 234
Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer Nuray ErinNur OganAzmi Yerlikaya Preclinical study 20 March 2018 Pages: 235 - 250
Correction to: Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer Nuray ErinNur OganAzmi Yerlikaya Correction 02 May 2018 Pages: 251 - 256
Circulating microRNAs from the miR-106a–363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer Minghui LiYan ZhouShui Wang Preclinical study Open access 20 March 2018 Pages: 257 - 270
A qualitative transcriptional signature to reclassify estrogen receptor status of breast cancer patients Hao CaiWenbing GuoJing Li Preclinical study 23 March 2018 Pages: 271 - 277
GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer Raksha R. BhatPuja YadavMeghana V. Trivedi Preclinical study 24 March 2018 Pages: 279 - 292
The role of programmed death ligand-1 and tumor-infiltrating lymphocytes in breast cancer overexpressing HER2 gene Yanchun LiMateusz OpyrchalThaer Khoury Clinical trial 09 March 2018 Pages: 293 - 302
Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial P. RoyA. LeizoroviczJ. Y. Bobin Clinical trial Open access 10 March 2018 Pages: 303 - 312
Radial scar on image-guided breast biopsy: is surgical excision necessary? Wendy Yen Yun ChouDeborah J. VeisRebecca Aft Clinical trial Open access 12 March 2018 Pages: 313 - 320
Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification Sally AgersborgChristopher MixonMaher Albitar Clinical trial Open access 22 March 2018 Pages: 321 - 328
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients Emanuela RisiAndrea GrilliLuca Malorni Clinical trial 22 March 2018 Pages: 329 - 341
Prediction of breast cancer risk with volatile biomarkers in breath Michael PhillipsRenee N. CataneoSonali Pathak Clinical trial 23 March 2018 Pages: 343 - 350
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00 Elisabetta MunzoneKathryn P. GrayMarco Colleoni Clinical trial 27 March 2018 Pages: 351 - 360
Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008–2011 Lauren E. WilsonCraig Evan PollackMichaela A. Dinan Epidemiology 13 March 2018 Pages: 361 - 371
Thirty-day postoperative morbidity and mortality in elderly women with breast cancer: an analysis of the NSQIP database Fernando A. AngaritaSergio A. AcunaTulin D. Cil Epidemiology 15 March 2018 Pages: 373 - 379
Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis Kathrin ThöneAnja RudolphDieter Flesch-Janys Epidemiology 19 March 2018 Pages: 381 - 390
Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening Francesca CaumoGiovanna RomanucciNehmat Houssami Epidemiology 20 March 2018 Pages: 391 - 397
Mutational analysis of candidate genes in Israeli male breast cancer cases Hagit SchayekHila KorachEitan Friedman Epidemiology 21 March 2018 Pages: 399 - 404
Breast cancer survival, survival disparities, and guideline-based treatment Deirdre A. HillSarah FriendMelanie Royce Epidemiology 22 March 2018 Pages: 405 - 414
Validation of a personalized risk prediction model for contralateral breast cancer Marzana ChowdhuryDavid EuhusPankaj Choudhary Epidemiology 24 March 2018 Pages: 415 - 423
A primary breast cancer with distinct foci of estrogen receptor-alpha positive and negative cells derived from the same clonal origin as revealed by whole exome sequencing Kelly Kyker-SnowmanBracha Erlanger AvigdorBen Ho Park Brief Report 15 March 2018 Pages: 425 - 430
Pre-operative progesterone benefits operable breast cancer patients by modulating surgical stress Shatakshee ChatterjeeRohan ChaubalPriyanka Pandey Brief Report 21 March 2018 Pages: 431 - 438
Breast screening and the parallel progression model of cancer Philippe Autier Letter to the Editor 13 March 2018 Pages: 439 - 440
Receptor conversion in breast cancer patients with liver metastases after hepatectomy might affect survival Kadri Altundag Letter to the Editor 20 March 2018 Pages: 441 - 441
A parallel model for breast cancer metastasis Jeff Boyd Letter to the Editor 21 March 2018 Pages: 443 - 444
